Publicaciones en las que colabora con Juan Antonio López García (19)

2022

  1. Characterization and functional performance of a commercial human conjunctival epithelial cell line

    Experimental Eye Research, Vol. 223

2020

  1. Histological and immunohistochemical characterization of the porcine ocular surface

    PLoS ONE, Vol. 15, Núm. 1

2019

  1. Topical application of TGF-β-activating peptide, KRFK, prevents inflammatory manifestations in the TSP-1-deficient mouse model of chronic ocular inflammation

    International Journal of Molecular Sciences, Vol. 20, Núm. 1

2018

  1. Improved in vitro corneal delivery of a thrombospondin-1-derived peptide using a liposomal formulation

    Experimental Eye Research, Vol. 167, pp. 118-121

  2. Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation

    International Journal of Pharmaceutics, Vol. 546, Núm. 1-2, pp. 20-30

2017

  1. Novel anti-inflammatory liposomal formulation for the pre-ocular tear film: In vitro and ex vivo functionality studies in corneal epithelial cells

    Experimental Eye Research, Vol. 154, pp. 79-87

2016

  1. Preliminary characterization of dexamethasone-loaded cross-linked hyaluronic acid films for topical ocular therapy

    International Journal of Pharmaceutics, Vol. 509, Núm. 1-2, pp. 237-243

2015

  1. Inflammatory Cytokine-Mediated Regulation of Thrombospondin-1 and CD36 in Conjunctival Cells

    Journal of Ocular Pharmacology and Therapeutics, Vol. 31, Núm. 7, pp. 419-428

  2. Thrombospondin-1 induces differential response in human corneal and conjunctival epithelial cells lines under invitro inflammatory and apoptotic conditions

    Experimental Eye Research, Vol. 134, pp. 1-14

2014

  1. CD44 and RHAMM hyaluronan receptors in human ocular surface inflammation

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 252, Núm. 8, pp. 1289-1295

  2. IL-6 as a corneal wound healing mediator in an invitro scratch assay

    Experimental Eye Research, Vol. 125, pp. 183-192

2013

  1. A nanomedicine to treat ocular surface inflammation: Performance on an experimental dry eye murine model

    Gene Therapy, Vol. 20, Núm. 5, pp. 467-477

  2. A new human primary epithelial cell culture model to study conjunctival inflammation

    Investigative ophthalmology & visual science, Vol. 54, Núm. 10, pp. 7143-7152

  3. Involvement of corneal epithelial cells in the Th17 response in an in vitro bacterial inflammation model

    Molecular Vision, Vol. 19, pp. 85-99

  4. Novel bioadhesive hyaluronan-itaconic acid crosslinked films for ocular therapy

    International Journal of Pharmaceutics, Vol. 455, Núm. 1-2, pp. 48-56

2012

  1. Hyaluronan receptors in the human ocular surface: A descriptive and comparative study of RHAMM and CD44 in tissues, cell lines and freshly collected samples

    Histochemistry and Cell Biology, Vol. 137, Núm. 2, pp. 165-176

  2. Structural and functional alteration of corneal epithelial barrier under inflammatory conditions

    Current Eye Research, Vol. 37, Núm. 11, pp. 971-981

2011

  1. Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles

    Molecular Pharmaceutics, Vol. 8, Núm. 5, pp. 1783-1788

  2. Intracellular trafficking of hyaluronic acid-chitosan oligomerbased nanoparticles in cultured human ocular surface cells

    Molecular Vision, Vol. 17, pp. 279-290